Mr Mrs Miss Ms Dr Other

Mr
Tim
Eyles

Board Chair and Non-Executive Director

Leeds Office

Operations

Telephone. +44(0) 113 233 0100
Email. teyles@hgf.com

Experience

Tim is a senior Board Chair with a diverse portfolio across professional services, financial services, healthcare, and the arts. He became Chair at HGF in October 2024 following completion of the investment by CBPE.

Tim is also Chair of Centralis Group, a global leader in specialist corporate, compliance and other services to international corporations and alternative asset managers, and Chair of Pacific Asset Management, a progressive asset management firm serving institutions, investors and advisers.

Tim has previously held Chair roles at other prominent organisations including the Royal Society of Arts (2018-2024), the Theatres Trust (a UK Government body), and Jerwood Arts, an arts charity supporting emerging artists. In recognition of his services to the arts, he was awarded an OBE in the 2023 New Year Honours list.

Tim was previously International Board Chair and Managing Partner at Taylor Wessing, the international law firm, which he led through a period of transformational growth from 2009 to 2018.

Industries

Services

Related News

PRESS RELEASE – HGF strengthens European presence with three new Partners in France and Germany

HGF is pleased to announce the arrival of three new partners, further strengthening its European presence. Two partners will be joining the firm’s fast-growing French practice, and one will join …

Read article

G1/23: The Enlarged Board of Appeal shift EPO practice towards an “on-sale” bar.

Last week, the EPO’s Enlarged Board of Appeal (EBA) issued its Decision that both a product put on the market before the date of filing of a European patent application, …

Read article

The EPO Board of Appeal comments on the scope of the morality exclusion from patentability

The recent decision, T1553/22 of the Board of Appeal required the Board to consider the scope of the exclusions from patentability under Article 53(a) EPC. The invention in this case …

Read article
Event - 4th November 2025

HGF are Silver Sponsors of LSPN Europe 2025

HGF is proud to be a Silver Sponsor of LSPN Europe 2025, a leading forum dedicated to helping life sciences innovators protect and leverage their intellectual property across the entire …

Event details
Event - 30th - 31st October 2025

RAPS European Digital Technologies and Software conference

HGF is proud to be attending the RAPS European Digital Technologies and Software conference in The Netherlands on 30th-31st October. HGF Partner and Patent Attorney Janine Swarbrick and Patent Director …

Event details

Protect It Before You Promote It: IP Advice for MedTech Innovators

Developed a new medical product? Check. Got tickets to an exciting MedTech conference to show off your new product? Check. Intellectual property? Pardon? In the excitement of bringing a new …

Read article

Agritech Thymes: The Bite of Implied Consent: Lessons from the Pink Lady Case

Can the supply of a plant variety without clear and defined restrictions on its use be an implicit consent to commercialise it? This case centres on the evidence required to …

Read article

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.